Northern Trust’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,501
Closed -$23K 4834
2022
Q1
$23K Hold
4,501
﹤0.01% 4659
2021
Q4
$30K Hold
4,501
﹤0.01% 4674
2021
Q3
$68K Buy
4,501
+3,466
+335% +$58.7K ﹤0.01% 4486
2021
Q2
$23K Hold
1,035
﹤0.01% 4535
2021
Q1
$27K Buy
1,035
+437
+73% +$11K ﹤0.01% 4427
2020
Q4
$9K Buy
598
+59
+11% +$1.85K ﹤0.01% 4349
2020
Q3
$18K Buy
+539
New +$26K ﹤0.01% 4229
2020
Q2
Sell
-279
Closed -$17K 4324
2020
Q1
$17K Hold
279
﹤0.01% 4105
2019
Q4
$22K Hold
279
﹤0.01% 4152
2019
Q3
$18K Hold
279
﹤0.01% 4163
2019
Q2
$15K Sell
279
-13
-4% -$2.26K ﹤0.01% 4191
2019
Q1
$63K Buy
292
+11
+4% +$4.44K ﹤0.01% 4006
2018
Q4
$97K Sell
281
-9
-3% -$6.99K ﹤0.01% 3928
2018
Q3
$337K Sell
290
-6
-2% -$5.53K ﹤0.01% 3723
2018
Q2
$253K Sell
296
-1,177
-80% -$978K ﹤0.01% 3780
2018
Q1
$1.73M Buy
1,473
+46
+3% +$50.8K ﹤0.01% 3182
2017
Q4
$1.32M Sell
1,427
-19
-1% -$17.5K ﹤0.01% 3320
2017
Q3
$1.59M Sell
1,446
-40
-3% -$45.5K ﹤0.01% 3309
2017
Q2
$1.71M Buy
1,486
+1,285
+639% +$1.56M ﹤0.01% 3264
2017
Q1
$232K Buy
201
+84
+72% +$81.1K ﹤0.01% 3752
2016
Q4
$123K Buy
117
+7
+6% +$3.18K ﹤0.01% 3859
2016
Q3
$44K Hold
110
﹤0.01% 4021
2016
Q2
$45K Hold
110
﹤0.01% 4029
2016
Q1
$47K Hold
110
﹤0.01% 4033
2015
Q4
$63K Sell
110
-1
-0.9% -$701 ﹤0.01% 4022
2015
Q3
$99K Buy
+111
New +$101K ﹤0.01% 3938
2015
Q2
Sell
-54
Closed -$77K 4297
2015
Q1
$77K Hold
54
﹤0.01% 4092
2014
Q4
$76K Buy
54
+1
+2% +$1.45K ﹤0.01% 4029
2014
Q3
$65K Sell
53
-262
-83% -$376K ﹤0.01% 4111
2014
Q2
$574K Sell
315
-117
-27% -$156K ﹤0.01% 3560
2014
Q1
$703K Buy
432
+60
+16% +$125K ﹤0.01% 3477
2013
Q4
$481K Buy
+372
New +$594K ﹤0.01% 3526

Other funds holding HSTO

Northern Trust's HSTO Position: Q2 2022 in Review

Northern Trust sold out of Histogen Inc. Common Stock (HSTO) in Q2 2022, closing a stake of 4,501 shares — an estimated $23K sold.

Northern Trust first reported a position in HSTO in Q4 2013 and held it in 32 quarters. The position peaked at $1.73M in Q1 2018. 10 funds tracked by Wall St. Rank hold HSTO as of Q2 2022.

  • Northern Trust reported no remaining Histogen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Northern Trust sold 4,501 Histogen Inc. Common Stock shares in Q2 2022, an estimated $23K.
  • Northern Trust first reported a position in Histogen Inc. Common Stock in Q4 2013 and held it in 32 quarters.
  • Northern Trust's Histogen Inc. Common Stock position peaked at $1.73M in Q1 2018.
  • 10 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2022.

Based on Northern Trust's 13F filing for Q2 2022, filed 12 Aug 2022.